
    
      This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed
      to assess the safety, efficacy, and tolerability of IDP-123 Lotion and IDP-123 Vehicle
      Lotion. To be eligible for the study subjects must be at least 9 years of age and have a
      clinical diagnosis of moderate to severe acne.
    
  